Your Title Text

The Cardiovascular Medical Research and Education Fund

Focus on IPAH (PPH)
Medical Research

The Cardiovascular Medical Research and Education Fund (CMREF) was created as a non-profit fund operated solely for charitable, scientific and educational purposes. The CMREF mission is the support of research to uncover the etiology and pathogenesis of idiopathic pulmonary arterial hypertension (IPAH, or PPH), in pursuit of the ultimate goal of its treatment and cure.

Specifically, the mission of the fund is to support education activities that will enhance the knowledge of pulmonary hypertension, and research projects that may help uncover the causes and pathogenesis of idiopathic pulmonary arterial hypertension (IPAH), in pursuit of the ultimate goal of its treatment and cure. 

Announcements:

APPLICATIONS FOR FUNDING OF RESEARCH PROJECTS

The CMREF does not have a formal application process to fund clinical research or educational projects, but is always interested in potentially providing full or partial support to initiatives that are novel, innovative, or address the spectrum of unmet medical needs related to pulmonary vascular diseases.

Interested parties should submit a Letter of Intent (maximum 2 pages) that describes the project sufficiently so that the Research Advisory Committee can understand the proposed goals and methods. In addition, the letter should mention the length of time of the project, and an estimated overall budget. Preference will be given to proposals that have budgets below $100,000 and timelines less than 2 years.

Please submit your letter, in electronic format, to Patt Wolfe, Executive Director, Cardiovascular Medical Research and Education Fund at patt.wolfe@ipahresearch.org The CMREF will respond within four weeks to inform you if a full application will be requested.

  • The members of the CMREF are sad to report the passing of Robyn Barst, MD, on April 19, 2013. She was an original member of the CMREF Research Advisory Committee and helped guide the CMREF in its mission to find treatments, prevention and cure for pulmonary hypertension. Her contributions to the field were enormous.
Website Builder